MedPath

Effect of Nebulized Milrinone on Right Ventricular Hemodynamics in Adult Cardiac Surgery

Phase 4
Conditions
Anesthesia
Interventions
Drug: Normal saline
Registration Number
NCT05132153
Lead Sponsor
Ain Shams University
Brief Summary

The primary aim of this study was to investigate the effect inhaled milrinone given before CPB on improving the right ventricular function measured by transesophageal echocardiography (TEE) at time of CPB separation.

Detailed Description

The investigator will include (70) patients planned for elective adult cardiac surgery (Coronary revascularization surgery, Mitral valve surgery, Aortic valve surgery or complex surgery (either two or more valves or valves and coronary revascularization surgery). All surgery should be with CPB. All patients will be diagnosed with preoperative PH. After separation of CPB the patients evaluated as regard the hemodynamics (MAP, HR), the inotropic score as additional intravenous milrinone in the case of low cardiac output or presence of post-CPB PH or RV failure with reduced contractility documented using TEE. Left ventricular EF, and right ventricular hemodynamics represented by RV function measured by (tricuspid annulus plane systolic excursion (TAPSE), fractional area change FAC), and right ventricular systolic pressure by doppler (RVSP) which represent the pulmonary artery pressure all data will be assessed by transesophageal ECHO after anesthesia, immediately before CPB and immediately after separation from CPB all these data will be recorded in the study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria
  • Cardiac surgery without CPB.
  • Hemodynamic instability in the preoperative time (defined as acute requirement for vasoactive support or mechanical device).
  • Adult congenital heart disease planned for corrective surgery.
  • Contraindication to transesophageal echocardiography (TEE).
  • Any surgery involves tricuspid valve annulus as it will compromise the accuracy of RV function assessment by TEE.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
(Group A) will receive milrinoneMilrinonePatients will receive milrinone 50 microgram/kg in 5ml volume, over 5 min by nebulization
(Group B) will receive normal salineNormal salinePatients will receive 5 ml saline by nebulization over 5 min
Primary Outcome Measures
NameTimeMethod
Effect of inhaled milrinone on improvement of right ventricular functionAfter 15 minutes of inhaled milrinone intraoperative and repeated after 12, 24 hours in intensive care unit

The right ventricle function will be assessed by Fractional area change ( Change in area between systole and diastole by echocardiograph ( intraoperative and postoperative)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Samar Soliman

🇪🇬

Cairo, Nasr City, Egypt

© Copyright 2025. All Rights Reserved by MedPath